AOD-9604 5mg Peptides
Built for disciplined research, this lyophilized peptide vial delivers the consistency and clarity serious laboratories expect.
The AOD-9604 lyophilized peptide vial is a research-grade, unflavored formulation presented as a stable powder for precise laboratory handling. This format supports controlled reconstitution and accurate aliquoting. Active ingredient: AOD-9604 peptide. Total strength: 5mg per vial.
- Each vial contains 5mg of AOD-9604, selected by researchers for investigations into growth hormone fragment analog activity, metabolic signaling pathways, and peptide stability under rigorously controlled conditions.
Engineered for laboratory workflows, the vial is designed to support clear, consistent reconstitution and reliable performance across repeated experiments. Researchers value its dependable lot-to-lot consistency, straightforward handling characteristics, and the clean, minimal profile appropriate for method development, assay validation, and exploratory studies. The lyophilized presentation helps preserve integrity through storage and transport, while enabling measured preparation according to protocol requirements established by qualified personnel.
Every detail of the presentation is selected for quality and control, from careful environmental handling during manufacturing to tamper-evident packaging and conscientious cold-chain logistics. Each lot is produced in the USA and evaluated against stringent specifications to support traceability, reliability, and alignment with research standards. Robust analytical testing, including HPLC and LC-MS identity and purity checks, is performed to help ensure a clean profile that researchers can trust when building reproducible methods and results.
Ingredients: AOD-9604.
Quality and compliance you can rely on: USA-based production, rigorous analytical verification, meticulous material handling, and lot-specific documentation reflect Peptide Scientific Labs’ commitment to precision. Certificates of Analysis are available to support documentation needs and method traceability. This product is supplied as a lyophilized research peptide and is intended strictly for qualified laboratory use.
For laboratory research only. Not for human or animal use. Not a drug, food, or cosmetic. Not for diagnostic use. Handle only by trained, authorized personnel following appropriate laboratory procedures and safety guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone, commonly described as the 176-191 region. In research settings it is presented as a peptide of interest in lipid-metabolism studies, with a profile intended to differ from full-length growth hormone. It should be framed as a research compound only.
What is AOD-9604 typically studied for?
AOD-9604 is most often studied in relation to fat metabolism, lipolysis, and body-weight regulation in experimental models. It is usually distinguished from full HGH by the fact that researchers investigate it for metabolic effects without assuming the broader growth-promoting actions of native growth hormone.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
This Product Contains
